Results 11 to 20 of about 607 (121)

Setbacks in the road to self-injection: a descriptive study of provider and mystery client reports on the DMPA-SC care-seeking experience in Nigeria [PDF]

Frontiers in Global Women's Health
This mixed-methods study describes perspectives from health providers and simulated clients on initiation and continuation of DMPA-SC for self-injection in Nigeria.
Madeline Griffith, Sneha Challa, Ayobambo Jegede, Ivan Idiodi, Chioma Okoli, Aminat Tijani, Shakede Dimowo, Awawu Grace Nmadu, Elizabeth Omoluabi, Jenny Liu   +9 more
doaj   +2 more sources

Factors associated with the acceptability of self-injection training by clients receiving DMPA-SC services from community pharmacies and patent and proprietary medicine vendors in Nigeria [PDF]

BMC Women's Health
Background The self-administration of the subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has the potential to empower women and improve contraceptive use. Several studies have demonstrated the acceptability of the provider-administered DMPA-SC,
Toyin O. Akomolafe, Emeka Emmanuel Okafor, Sikiru Baruwa, Osimhen Ubuane, Michael Alagbile, Delafrida Ukaga, Ijeoma Nwankwo, Rodio Diallo   +7 more
doaj   +2 more sources

Determinants of DMPA-SC self-care/self-injectable contraceptive uptake among modern contraceptive users in Burkina Faso: findings from the 2021 demographic and health survey [PDF]

Frontiers in Global Women's Health
IntroductionThis study aimed to identify the determinants that influence the use of DMPA-SC/Sayana Press among women who use modern contraceptive methods in Burkina Faso.MethodsThis study used secondary data obtained from the 2021 Burkina Faso ...
Aristide Romaric Bado
doaj   +2 more sources

Introduction of Community-Based Provision of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Benin: Programmatic Results. [PDF]

Glob Health Sci Pract, 2019
The Republic of Benin faces high maternal, newborn, and child mortality; low modern contraceptive use; and a critical shortage of health workers. In 2013, the Government of Benin made 3 reproductive health commitments to improve national health indicators, including expanding provision of family planning services at the community level through task ...
Okegbe T, Affo J, Djihoun F, Zannou A, Hounyo O, Ahounou G, Bangbola KA, Harris N.   +7 more
europepmc   +4 more sources

Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects. [PDF]

Contraception, 2018
In 2015, private healthcare providers in Nigeria introduced DMPA-SC (depot medroxyprogesterone acetate administered subcutaneously) into the method mix. We aimed to [1] examine the sociodemographic predictors of continued DMPA-SC use after 3 months, and [2] characterize the additional influences of contraceptive counseling quality and experiences of ...
Liu J, Shen J, Diamond-Smith N.
europepmc   +6 more sources

Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC). [PDF]

Eval Program Plann, 2018
In collaboration with ministries of health, PATH and key partners launched the first pilot introductions of subcutaneous depot medroxyprogesterone acetate (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda from July 2014 through June 2016.
Stout A, Wood S, Namagembe A, Kaboré A, Siddo D, Ndione I.   +5 more
europepmc   +3 more sources

Task-shifting the provision of DMPA-SC in the DR Congo: Perspectives from two different groups of providers. [PDF]

Contraception, 2018
To document the experience of three groups of Family Planning service providers participating in task-shifting for the provision of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) at the community level in the DRC.This article compares results from interviews with DMPA-SC providers in two separate pilot studies: 1) 53 medical and nursing ...
Hernandez JH, Akilimali P, Glover A, Emel R, Mwembo A, Bertrand J.   +5 more
europepmc   +4 more sources

Enhancing the Introduction and Scale Up of Self-Administered Injectable Contraception (DMPA-SC) in Health Systems (the EASIER Project): Protocol for Embedded Implementation Research

JMIR Research Protocols, 2023
BackgroundThe introduction of self-administered injectable contraception presents an opportunity to address the unmet need for family planning.
Colin Baynes, Petrus S Steyn, Kenneth Sherr, James Kiarie   +3 more
doaj   +2 more sources

How do pro-social tendencies and provider biases affect service delivery? Evidence from the rollout of self-injection of DMPA-SC in Nigeria [PDF]

BMC Women's Health
Background Inconsistent provision of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) for self-injection (SI) undermines efforts to improve women’s reproductive health agency and access to self-care.
Calvin Chiu, Aminat Tijani, Madeline Griffith, Emily Himes, Sneha Challa, Chioma Okoli, Shakede Dimowo, Ayobambo Jegede, Jenny X. Liu   +8 more
doaj   +2 more sources

Patterns of triggers, ideation and motivational factors of contraceptive utilization among women and gate-keepers in Nigeria: a scoping study on the resilient and accelerated scale up of DMPA-SC in Nigeria (RASUDIN) [PDF]

Contraception and Reproductive Medicine, 2020
Background Women have unfair share in the burden of unintended pregnancy outcome and unhealthy interpregnancy intervals. An understanding of the triggers, ideation and motivational factors influencing utilization of modern contraceptives is relevant for ...
Kehinde Osinowo, Michael Ekholuenetale, Oluwaseun Ojomo, Abiodun Hassan, Oladapo Alabi Ladipo   +4 more
doaj   +2 more sources